-
Hundred billion "chronic disease market" is very attractive, Yangtze River, East China Medicine Show your powers and speed up the layout
Time of Update: 2019-12-06
[pharmaceutical network market analysis] at present, China's elderly population has reached 249 million With the increasing of aging, the economic burden caused by chronic diseases will further increa
-
Global innovation! Sansheng pharmaceutical is authorized by the new target of immunotherapy PSGL-1 mAb, reprogramming macrophages to stimulate synergistic antitumor response
Time of Update: 2019-11-18
November 18, 2019 / BIOON / - sansbio pharmaceutical and Verseau therapeutics announced today that according to the cooperation agreement on the development and commercialization of innovative monoclo
-
"Innovative drugs" of large pharmaceutical enterprises and small pharmaceutical enterprises listed in succession can also "reverse the wind
Time of Update: 2019-11-15
On November 13, the drug evaluation center (CDE) of the State Food and Drug Administration (SFDA) completed the technical evaluation of the application for registration of Baiji Shenzhou PD-1 tirizuma
-
Medical AI assisted VTE prevention and treatment, Huiyi technology tried to solve the problem of prevention and treatment of pulmonary embolism with new technology
Time of Update: 2019-11-01
Since the late 1980s, surgeons such as caprini have been committed to the research and design of a very detailed individual risk assessment model for VTE, and constantly optimize its accuracy and clin
-
Hospital out! Medical Insurance Bureau of 20 hospitals directly settles accounts with suppliers
Time of Update: 2019-09-27
Hospital out, medical insurance and suppliers directly settle the payment! Another city landed! On September 26, 20 hospitals and medical insurance bureau issued the notice on opening centralized sett
-
How are pharmaceutical enterprises preparing for the day of submission
Time of Update: 2019-08-27
[pharmaceutical network industry trends] August of this year is coming to an end For pharmaceutical companies, this is very stressful According to the relevant requirements of the Ministry of finance,
-
Heilongjiang document indicates that the position of base drug cannot be shaken, and rational use of base drug is the key
Time of Update: 2019-07-24
On July 23, Heilongjiang Health Committee publicized the notice on Further Strengthening the allocation and use management of essential drugs in public medical institutions According to the opinions o
-
Under the pressure of environmental protection, pharmaceutical enterprises are faced with "internal worries" and "external troubles
Time of Update: 2019-05-15
[pharmaceutical Station market analysis] "internal worries", in the context of frequent environmental protection policies and regulatory policies of pharmaceutical enterprises, pharmaceutical enterpri
-
[exclusive] analysis of drugs included in the priority review: Zhengda Tianqing, Hengrui, Huahai, Bayer, Novartis
Time of Update: 2019-02-27
Highlights: 1 Trend of undertaking, 2015-2016 key year; 2 Approval rate of production report: new drug 25.78%, generic drug 26.84%, imported drug 65.82%; 3 Clinical approval rate: new drug 78.69%, gen
-
Medicine anti-corruption efforts to increase the ban of these pharmaceutical companies from Wuxi public hospitals for three years
Time of Update: 2019-01-07
[China Pharmaceutical network industry trends] on January 3, Wuxi health and Family Planning Commission issued the notice on the establishment of regulations on bad records and "blacklist" of drug, me
-
[exclusive] mid year report of 2018 domestic clinical trial
Time of Update: 2018-07-18
With the introduction of "self inspection and verification of clinical trial data" and "consistency evaluation of quality and efficacy of generic drugs" and other policies, the attention of clinical t
-
A panoramic observation of imported new drugs approved by CFDA in 2017 (1
Time of Update: 2018-03-23
Source: drug era March 23, 2018 According to the published data of CFDA / CDE, this paper combines new chemical drugs (NME / and its compound drugs) and biological drugs (BLA) After searching on CFDA
-
Shaanxi will establish 11 drug storage bases in short supply
Time of Update: 2017-11-29
Source: Xinhuanet, November 29, 2017 The reporter learned from the health and Family Planning Commission of Shaanxi Province that Shaanxi Province has recently issued the implementation plan for the r
-
Preliminary results have been achieved in the pilot program of drug listing license holder system
Time of Update: 2017-11-24
Source: economic reference report 2017-11-24 The first pharmaceutical policy and industry innovation and development forum hosted by China Pharmaceutical News and Information Association and China Pha
-
How do pharmaceutical companies perform in compliance
Time of Update: 2017-08-12
[market analysis of China Pharmaceutical network] the report funded by the bill and Melinda Gates Foundation has been published since 2008, once every two years The report, released last month, lists
